SYRE
Spyre Therapeutics, Inc.When SYRE passed all Ten ChecksSpyre Therapeutics, Inc.
history · not a forecastOver the past 10 years, SYRE has passed all Ten Checks on 9 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +30.2% in Feb 2026, peaked day 7.
- Feb 2026+30.2% +2.7%
- Sep 2024+6.9% -4.3%
- Aug 2021+9.7% -4.5%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about SYRE’s checks
How many technical checks does SYRE pass right now?
As of the Aug 13, 2026 close, SYRE passes 8 of 10 fixed technical checks — the checks not passing: holding above short-term average, adequate stop room.
Why does SYRE fail the "holding above short-term average" check?
SYRE closed at $101.85, 0.9% below its 9-day average ($102.73), so this momentum check fails. It passes again on a close above $102.73.
What price would change SYRE's check count?
The nearest flip level is "stop distance within range" fails on a close outside $101.01 – $107.60. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.